Key facts
| Company | Pamex Foods Incorporated |
|---|---|
| FDA office | Office of Inspections and Investigations |
| Letter date | May 26, 2026 |
| Subject / product | Foreign Supplier Verification Program (FSVP) |
| CFR citations | FDA Warning Letter |
| Response due | 15 working days from receipt (standard FDA warning-letter requirement) |
| Reference / source ID | pamex-foods-incorporated-730351-05262026 |
What happens next
Pamex Foods Incorporated is expected to respond to FDA in writing, typically within 15 working days of the letter date, describing the specific corrective and preventive actions taken or planned for each violation cited. FDA reviews that response and any follow-up evidence, and can conduct a re-inspection to confirm the corrections were actually made. If FDA judges the response inadequate, or the underlying conditions serious enough, further action can follow, including product seizure, injunction, import alert, or civil penalties; many Warning Letters are resolved through corrective action alone. This page reflects the Warning Letter as issued and will not reflect any subsequent correction unless FDA publishes a follow-up record. FDA issues Warning Letters after an inspection or other review when it believes a firm has significantly violated FDA regulations; the letter itself is a notice, not a final adjudication.
Violations explained
FDA Warning Letter — Violations FDA cited at Pamex Foods Incorporated
WARNING LETTER Pamex Foods Incorporated MARCS-CMS 730351 — May 26, 2026 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: Via Email Product: Food & Beverages Recipient: Recipient Name Javier Ramirez Recipient Title President Pamex Foods Incorporated 7900 Parston Drive District Heights , MD 20747-4426 United States Javier@pamexfood.com Issuing Office: Office of Inspections and Investigations United States WARNING LETTER Re: CMS # 730351 Dear Mr. Ramirez: On January 30 to February 10, 2026, the Food and Drug Administration conducted a Foreign Supplier Verification Program (FSVP) inspection of Pamex Foods Incorporated located at 7900 Parston Drive, District Heights, MD 20747-4426. We also conducted an inspection on November 15 to 28, 2022. These inspections were conducted to determine compliance with the requirements of section 805 of the Federal Food, Drug and Cosmetic Act (FD&C Act) (21 U.S.C. 384a) and the implementing FSVP regulation in 21 CFR part 1 subpart L. The FSVP regulation requires that importers perform certain risk-based activities to verify that human and/or animal food they import into the United States has been produced in a manner that meets applicable U.S. food safety standards. You may find information relating to the FSVP regulation and your responsibilities to comply with the regulation through links in FDA’s FSVP web page at https://www.fda.gov/food/food-safety-modernization-act-fsma/fsma-final-rule-foreign-supplier-verification-programs-fsvp-importers-food-humans-and-animals. During the most recent inspection, we found that you are not in compliance with the requirements of 21 CFR part 1, subpart L for the foods you import. Because of this significant violation, you are not in compliance with section 805 of the FD&C act. At the conclusion of the inspection, our investigator provided you with a Form FDA 483a FSVP Observations. We acknowledge receipt of your response, dated February 25, 2026, in which you provided your corrective action plan (CAP). You stated that you hired (b)(4) and your firm would be in compliance within a few weeks. You also stated that you (b)(4) . FDA requested updates on your CAP on March 2, 2026, and April 1, 2026. You did not provide a response. We are unable to evaluate the adequacy of your response because you have not provided any supporting documentation demonstrating your corrective actions. To date, no FSVP documents have been received. Your significant violations of the FSVP regulations are as follows: You did not develop, maintain, and follow an FSVP as required by section 805 of the FD&C Act and 21 CFR 1.502(a). Specifically, you did not develop an FSVP for any of the foods you import, including each of the following foods: English sauce/Worcestershire Sauce imported from (b)(4) located in the (b)(4) Frozen stuffed corn tortilla imported from (b)(4) located in (b)(4) Corn flour imported from (b)(4) located in (b)(4) The above violations are not intended to be an all-inclusive list of violations of the FSVP requirements. It is your responsibility to ensure that you are in compliance with section 805 of the FD&C Act and the implementing regulation in 21 CFR part 1, subpart L. In addition, FDA has determined that your facility located at 7900 Parston Drive, District heights, MD 20747-4426 is subject to the food facility registration requirement in section 415 of the FD&C Act (21 U.S.C. 350d) and our implementing regulations at 21 CFR part 1, subpart H. During the most recent inspection, you were advised of this requirement. (b)(3)(A) . Failure to register a facility as required is a prohibited act under section 301(dd) of the FD&C Act (21 U.S.C. 331(dd)). As a responsible official of a facility that manufactures/processes, packs, or holds food for human or animal consumption in the United States, you are responsible for ensuring that your overall operation and the products you distribute are in compliance with the law. We request that th
Pamex Foods Incorporated’s FDA history
Argus HQ has recorded 1 total FDA action tied to Pamex Foods Incorporated: 1 warning letter, 0 recalls, 0 approval records, and 0 Form 483 inspection citations.
Full letter text
Read the rest of the full text
Frequently asked questions
- What is the standard FDA response window for a warning letter?
- FDA warning letters typically require a written response within 15 working days of receipt, outlining the corrective and preventive actions the company will take.
- What is an FDA Warning Letter?
- An FDA Warning Letter notifies a company that FDA believes it has significantly violated FDA regulations and that prompt corrective action is required. It is issued after an inspection, sample analysis, or other FDA review, and is a notice -- not a final legal determination and not itself a penalty.
- Does this Warning Letter mean Pamex Foods Incorporated violated the law?
- FDA's letter documents violations it believes it found at Pamex Foods Incorporated. A Warning Letter is not a final adjudication of guilt; the company has an opportunity to respond and correct the cited issues, and many Warning Letters are resolved without further enforcement once FDA confirms adequate correction.
- What happens after a Warning Letter is issued?
- The firm generally must respond in writing within 15 working days; FDA reviews the response and can escalate to seizure, injunction, or import alert if it judges the response inadequate. Many Warning Letters are resolved through corrective action alone.
Get the next warning letter in this therapeutic area before your team hears about it secondhand.
Weekly briefing, free. Upgrade any time for daily or real-time delivery.
Related enforcement actions
Full FDA history for Pamex Foods Incorporated- Warning letter (recent): Med Shop Inc / www.medshopinc.com — Unapproved New Drugs/Misbranded (2026-06-23) →
- Warning letter (recent): ketaminetroches.com — Unapproved New Drugs/Misbranded (2026-06-23) →
- Warning letter (recent): Ketdaxandrugs / www.ketdaxandrugs.org — Unapproved New Drugs/Misbranded (2026-06-23) →
- Warning letter (recent): Legit Ketamine Suppliers / www.legitketaminesuppliers.com — Unapproved New Drugs/Misbranded (2026-06-23) →
- Warning letter (recent): Ketamine Store / www.ketaminestore.org — Unapproved New Drugs/Misbranded (2026-06-23) →
- Warning letter (recent): Buy Keta Online / www.buyketaonline.com — Unapproved New Drugs/Misbranded (2026-06-23) →
- Warning letter (recent): Ketamine Troche Store / www.ketaminetrochestore.com — Unapproved New Drugs/Misbranded (2026-06-23) →
- Warning letter (recent): All Ketamine HCL / www.allketaminehcl.com — Unapproved New Drugs/Misbranded (2026-06-23) →
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). FDA Warning Letter to Pamex Foods Incorporated (May 26, 2026) — Foreign Supplier Verification Program (FSVP). Digital Empire LLC. Retrieved from https://argushq.ai/warning-letter/pamex-foods-incorporated-730351-2026-05-26
"FDA Warning Letter to Pamex Foods Incorporated (May 26, 2026) — Foreign Supplier Verification Program (FSVP)." Argus HQ Research, Digital Empire LLC, 2026, argushq.ai/warning-letter/pamex-foods-incorporated-730351-2026-05-26.
Argus HQ Research. "FDA Warning Letter to Pamex Foods Incorporated (May 26, 2026) — Foreign Supplier Verification Program (FSVP)." Digital Empire LLC. Accessed July 13, 2026. https://argushq.ai/warning-letter/pamex-foods-incorporated-730351-2026-05-26.
@misc{argushq_argushq_ai_warning_letter_pamex_foods_incorporated_730351_2026_05_26_2026,
title = {FDA Warning Letter to Pamex Foods Incorporated (May 26, 2026) — Foreign Supplier Verification Program (FSVP)},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire LLC},
url = {https://argushq.ai/warning-letter/pamex-foods-incorporated-730351-2026-05-26},
note = {Accessed: July 13, 2026}
}Source: FDA.gov — Warning Letters ↗

